ReviewFrontiers in oncology2024

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives.

Yurou Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.